Boehringer spearheads green push in China

Carbon neutrality is both achievable and profitable for corporations in pursuit of long-term development, according to German pharmaceutical company Boehringer Ingelheim.

The company's production facility in Zhangjiang, in Shanghai's Pudong New Area, recently attained carbon neutral certification from the Guangzhou Emission Exchange and TUV Rheinland, making it the first carbon neutral plant in China's pharmaceutical industry to be certified by both domestic and foreign authorities, the company announced on Friday.

An important pilot project under the global sustainable development strategy of BI, which plans to have all its operations attain carbon neutrality by 2030, the Zhangjiang plant achieved peaked carbon emissions in 2014 and has since been pursuing carbon neutrality through energy-saving projects, through a switch to green energy and partnering with internationally verified carbon offsetting organizations, according to Yin Xuelin, general manager of Boehringer Ingelheim Shanghai Pharmaceutical Co.